• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏:高密度脂蛋白水平及功能的关键调节因子。

Kidneys: key modulators of high-density lipoprotein levels and function.

作者信息

Yang Haichun, Fogo Agnes B, Kon Valentina

机构信息

aDepartments of Pediatrics, Microbiology, and Immunology bDepartments of Medicine, Microbiology, and Immunology cDepartments of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

出版信息

Curr Opin Nephrol Hypertens. 2016 May;25(3):174-9. doi: 10.1097/MNH.0000000000000217.

DOI:10.1097/MNH.0000000000000217
PMID:27008596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4899840/
Abstract

PURPOSE OF REVIEW

The review will examine advances in our understanding of the role kidneys play in high-density lipoprotein (HDL) metabolism and the effect on levels, composition, and function of HDL particles.

RECENT FINDINGS

Components of the HDL particles can cross the glomerular filtration barrier. Some of these components, including apolipoproteins and enzymes involved in lipid metabolism, are taken up by the proximal tubule and degraded, modified, salvaged/returned to the circulation, or lost in the urine. Injury of the glomerular capillaries or tubules can affect these intrarenal processes and modify HDL. Changes in the plasma and urine levels of HDL may be novel markers of kidney damage or mechanism(s) of kidney disease.

SUMMARY

The kidneys have a significant role in the metabolism of individual HDL components, which in turn modulate HDL levels, composition, and functionality of HDL particles. These intrarenal effects may be useful markers of kidney damage and have consequences on kidney-related perturbations in HDL.

摘要

综述目的

本综述将探讨我们对肾脏在高密度脂蛋白(HDL)代谢中所起作用的理解进展,以及对HDL颗粒水平、组成和功能的影响。

最新发现

HDL颗粒的成分可穿过肾小球滤过屏障。其中一些成分,包括参与脂质代谢的载脂蛋白和酶,被近端小管摄取并降解、修饰、回收/返回循环或随尿液流失。肾小球毛细血管或肾小管的损伤会影响这些肾内过程并改变HDL。HDL血浆和尿液水平的变化可能是肾脏损伤或肾脏疾病机制的新标志物。

总结

肾脏在单个HDL成分的代谢中起重要作用,进而调节HDL颗粒的水平、组成和功能。这些肾内效应可能是肾脏损伤的有用标志物,并对HDL中与肾脏相关的紊乱产生影响。

相似文献

1
Kidneys: key modulators of high-density lipoprotein levels and function.肾脏:高密度脂蛋白水平及功能的关键调节因子。
Curr Opin Nephrol Hypertens. 2016 May;25(3):174-9. doi: 10.1097/MNH.0000000000000217.
2
Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.脂毒性和慢性肾脏病中高密度脂蛋白介导的胆固醇逆转运受损。
J Ren Nutr. 2010 Sep;20(5 Suppl):S35-43. doi: 10.1053/j.jrn.2010.05.010.
3
Disorders in high-density metabolism with insulin resistance and chronic kidney disease.伴有胰岛素抵抗和慢性肾脏病的高密度代谢紊乱
J Ren Nutr. 2007 Jan;17(1):4-8. doi: 10.1053/j.jrn.2006.10.002.
4
Proteomics investigations of HDL: challenges and promise.蛋白质组学研究 HDL:挑战与前景。
Curr Vasc Pharmacol. 2012 Jul;10(4):410-21. doi: 10.2174/157016112800812755.
5
Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.高密度脂蛋白(HDL)相关的1-磷酸鞘氨醇与血清HDL胆固醇及载脂蛋白水平的相关性。
Atherosclerosis. 2005 Jan;178(1):199-205. doi: 10.1016/j.atherosclerosis.2004.08.024.
6
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.烟酸疗法对血浆高密度脂蛋白亚组分分布与组成及载脂蛋白A代谢的影响。
J Clin Invest. 1979 May;63(5):858-67. doi: 10.1172/JCI109385.
7
Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins.血浆高密度脂蛋白载脂蛋白及相关蛋白的蛋白质组学研究
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):156-63. doi: 10.1161/ATVBAHA.108.179317. Epub 2009 Sep 24.
8
Urinary high density lipoprotein--a possible marker for glomerular proteinuria.
Cent Afr J Med. 1991 Jul;37(7):211-6.
9
The effects of physical exercise on plasma prebeta-1 high-density lipoprotein.体育锻炼对血浆前β-1高密度脂蛋白的影响。
Metabolism. 2003 Apr;52(4):437-42. doi: 10.1053/meta.2003.50086.
10
Epidemiology: disease associations and modulators of HDL-related biomarkers.流行病学:疾病关联以及高密度脂蛋白相关生物标志物的调节因素
Handb Exp Pharmacol. 2015;224:259-83. doi: 10.1007/978-3-319-09665-0_7.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?糖尿病肾病患者中的高密度脂蛋白:是友还是敌?
Int J Mol Sci. 2025 Feb 16;26(4):1683. doi: 10.3390/ijms26041683.
3
Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

本文引用的文献

1
RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis.RNA测序鉴定出肾纤维化的新型翻译生物标志物。
J Am Soc Nephrol. 2016 Jun;27(6):1702-13. doi: 10.1681/ASN.2015020225. Epub 2015 Oct 8.
2
HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.高密度脂蛋白胆固醇流出功能可预测肾移植受者的移植物失功
J Am Soc Nephrol. 2016 Feb;27(2):595-603. doi: 10.1681/ASN.2014090857. Epub 2015 Aug 28.
3
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.
代谢功能障碍相关脂肪性肝病患者血脂异常管理的实用方法
J Lipid Atheroscler. 2025 Jan;14(1):5-29. doi: 10.12997/jla.2025.14.1.5. Epub 2024 Jun 26.
4
Insights into the renal pathophysiology in Hermansky-Pudlak syndrome-1 from urinary extracellular vesicle proteomics and a new mouse model.基于尿液细胞外囊泡蛋白质组学及新型小鼠模型对赫尔曼斯基-普德拉克综合征1型肾脏病理生理学的见解
FEBS Lett. 2025 Apr;599(7):1055-1074. doi: 10.1002/1873-3468.15088. Epub 2024 Dec 30.
5
Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews.理解慢性肾脏病中高密度脂蛋白的异质性和功能障碍:来自最新综述的见解。
BMC Nephrol. 2024 Nov 7;25(1):400. doi: 10.1186/s12882-024-03808-3.
6
Anti-inflammatory mechanism of Apolipoprotein A-I.载脂蛋白 A-I 的抗炎机制。
Front Immunol. 2024 Jul 8;15:1417270. doi: 10.3389/fimmu.2024.1417270. eCollection 2024.
7
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.肥胖、血脂异常与心血管疾病:肥胖医学协会和国家脂质协会2024年联合专家综述
Obes Pillars. 2024 Mar 12;10:100108. doi: 10.1016/j.obpill.2024.100108. eCollection 2024 Jun.
8
Multi-molecular hyperspectral PRM-SRS microscopy.多分子高光谱 PRM-SRS 显微镜。
Nat Commun. 2024 Feb 21;15(1):1599. doi: 10.1038/s41467-024-45576-6.
9
Total Outflow of High-Density Lipoprotein-Cholesteryl Esters from Plasma Is Decreased in a Model of 3/4 Renal Mass Reduction.血浆高密度脂蛋白胆固醇酯的总流出量在 3/4 肾质量减少模型中减少。
Int J Mol Sci. 2023 Dec 4;24(23):17090. doi: 10.3390/ijms242317090.
10
The biodistribution of placental and fetal extracellular vesicles during pregnancy following placentation.胎盘和胎儿细胞外囊泡在胎盘形成后妊娠期间的体内分布。
Clin Sci (Lond). 2023 Mar 15;137(5):385-399. doi: 10.1042/CS20220301.
高密度脂蛋白胆固醇外排能力与冠心病事件发生的相关性:一项前瞻性病例对照研究。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):507-13. doi: 10.1016/S2213-8587(15)00126-6. Epub 2015 May 27.
4
Dialysis Modalities and HDL Composition and Function.透析方式与高密度脂蛋白的组成及功能
J Am Soc Nephrol. 2015 Sep;26(9):2267-76. doi: 10.1681/ASN.2014030309. Epub 2015 Mar 5.
5
Dysfunctional high-density lipoproteins in children with chronic kidney disease.慢性肾病患儿中功能失调的高密度脂蛋白。
Metabolism. 2015 Feb;64(2):263-73. doi: 10.1016/j.metabol.2014.10.020. Epub 2014 Oct 25.
6
HDL cholesterol efflux capacity and incident cardiovascular events.高密度脂蛋白胆固醇流出能力与心血管事件的发生
N Engl J Med. 2014 Dec 18;371(25):2383-93. doi: 10.1056/NEJMoa1409065. Epub 2014 Nov 18.
7
Arginine-directed glycation and decreased HDL plasma concentration and functionality.精氨酸定向糖基化与 HDL 血浆浓度和功能降低。
Nutr Diabetes. 2014 Sep 1;4(9):e134. doi: 10.1038/nutd.2014.31.
8
Restoration of renal function does not correct impairment of uremic HDL properties.肾功能的恢复并不能纠正尿毒症高密度脂蛋白(HDL)特性的损害。
J Am Soc Nephrol. 2015 Mar;26(3):565-75. doi: 10.1681/ASN.2013111219. Epub 2014 Jul 28.
9
Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.获得性卵磷脂胆固醇酰基转移酶缺乏症是慢性肾脏病患者降低血浆高密度脂蛋白水平的主要因素。
J Intern Med. 2015 May;277(5):552-61. doi: 10.1111/joim.12290. Epub 2014 Aug 1.
10
APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.APOL1 风险变异通过损害溶酶体膜通透性增强足细胞坏死。
Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F326-36. doi: 10.1152/ajprenal.00647.2013. Epub 2014 Jun 4.